CERS

CERUS CORP

Nasdaq · Surgical & Medical Instruments & Apparatus · Inc. DE · CIK 0001020214
$2.56 -1.16% $512.9M
Insider Selling Cluster (2 insiders)High Impact Filing (7/10)9 New Institutional Positions6 Institutional Exits
Vol
Market Cap$512.9M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (89%)
Inst. Holders50 funds
Inst. Value$191.2M
Inst. Activity9 buys / 6 sells
Insider Activity0B / 19S
Insider Net $-$2.7M
SEC Reports6
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001020214·Prev Close $2.59

Recent Activity

Jun 9, 2026 Insider
BJERKHOLT ERIC sold 20,454 shares
Director @ $2.60 ($53.2K)
Jun 2, 2026 Insider
Lucena Ann was granted 60,000 shares
Director
Jun 2, 2026 Insider
BJERKHOLT ERIC was granted 60,000 shares
Director
May 15, 2026 short_volume
Short Volume: CERS — 55.5% short (0.6M / 1.1M)
Short: 612,926 | Exempt: 25 | TRF Vol: 1,104,545 | Short Ratio: 55.5% | Off-exchange volume (dark po
Apr 30, 2026 SEC
Cerus Corp reported Q1 2026 product revenue of $53.7M (+24% YoY), beating consensus estimates, and narrowed its net loss
8-K — Impact 7/10
Apr 22, 2026 SEC
Cerus Corporation filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, proposing the election of tw
DEFA14A — Impact 3/10
Apr 21, 2026 SEC
Cerus Corporation adopted a new severance plan on April 17, 2026, establishing enhanced severance benefits for certain e
8-K — Impact 3/10
Inst.
Assenagon Asset Management S.A. — TRIM
1,251,093 shares ($2.3M)

Price Targets

$4.67 +82.3% upside Strong Buy
Current $2.56 Low $4.00 Median $5.00 High $5.00 3 analysts
$4.00 $5.00

Analyst Ratings

Strong Buy89% buy · 9 analysts
3Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 1, 2026 BTIG UPGRADE Neutral → Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.01 ▲ +60.0% $-0.01 — $-0.01 67% YoY 2
Next Q $-0.01 ▼ -100.0% $-0.01 — $-0.01 0% YoY 2
Current FY $-0.03 ▲ +50.0% $-0.04 — $-0.02 63% YoY 2

Latest Reports

BULLISH 8-K 7/10
Cerus Corp reported Q1 2026 product revenue of $53.7M (+24% YoY), beating consensus estimates, and narrowed its net loss
Apr 30, 2026
NEUTRAL DEFA14A 3/10
Cerus Corporation filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, proposing the election of tw
Apr 22, 2026

Top Institutional Holders

FundValueMove
BlackRock, Inc.$39.3M—
ARK Investment Management LLC$34.9M—
BAKER BROS. ADVISORS LP$18.2MTRIM
VANGUARD CAPITAL MANAGEMENT LLC$14.8M—
WASATCH ADVISORS LP$9.6MTRIM

Recent Insider Trades

DateInsiderTypeValue
Jun 9, 2026BJERKHOLT ERICSELL$53.2K
Jun 2, 2026Lucena AnnA$0.00
Jun 2, 2026BJERKHOLT ERICA$0.00
Jun 2, 2026NACHTSHEIM JAMIA$0.00
Jun 2, 2026Witney FrankA$0.00
50 institutional holders with $191.2M total value (105,033,738 shares) as of 2026-Q1. Top holders: BlackRock,, ARK, BAKER. Net buying activity: 9 institutions added/increased vs 6 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1BlackRock, Inc.21,575,419$39.3M20.5%—
2ARK Investment Management LLC19,161,148$34.9M18.2%—
3BAKER BROS. ADVISORS LP10,008,345$18.2M9.5%TRIM -33.4%
4VANGUARD CAPITAL MANAGEMENT LLC8,131,778$14.8M7.7%—
5WASATCH ADVISORS LP5,281,136$9.6M5.0%TRIM -35.1%
6Sumitomo Mitsui Trust Group, Inc.4,516,606$8.2M4.3%—
7SILVERCREST ASSET MANAGEMENT GROUP LLC4,241,411$7.7M4.0%—
8STATE STREET CORP4,214,902$7.7M4.0%—
9D. E. Shaw & Co., Inc.3,731,151$6.8M3.6%—
10GOLDMAN SACHS GROUP INC2,768,603$5.0M2.6%—
11TWO SIGMA INVESTMENTS, LP2,745,021$5.0M2.6%ADD +62.3%
12VANGUARD PORTFOLIO MANAGEMENT LLC1,919,067$3.5M1.8%—
13CHARLES SCHWAB INVESTMENT MANAGEMENT INC1,630,069$3.0M1.6%—
14VANGUARD FIDUCIARY TRUST CO1,304,098$2.4M1.2%—
15Assenagon Asset Management S.A.1,251,093$2.3M1.2%TRIM -25.4%
16BANK OF AMERICA CORP /DE/1,218,330$2.2M1.2%DOUBLED +2289.4%
17FMR LLC1,205,737$2.2M1.1%ADD +25.3%
18VOYA INVESTMENT MANAGEMENT LLC1,107,348$2.0M1.1%—
19DRIEHAUS CAPITAL MANAGEMENT LLC961,606$1.8M0.9%—
20MORGAN STANLEY825,984$1.5M0.8%TRIM -57.4%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
Assenagon Asset Management S.A.TRIM1,676,2791,251,093-25.4%$2.3M2026-Q1
MORGAN STANLEYTRIM1,940,157825,984-57.4%$1.5M2026-Q1
Russell Investments Group, Ltd.DOUBLED65,442466,036+612.1%$848.2K2026-Q1
AMERIPRISE FINANCIAL INCADD347,000454,051+30.9%$826.4K2026-Q1
Invesco Ltd.ADD309,168407,613+31.8%$741.9K2026-Q1
Nuveen, LLCTRIM840,460393,186-53.2%$715.6K2026-Q1
PANAGORA ASSET MANAGEMENT INCDOUBLED92,501305,246+230.0%$555.5K2026-Q1
WEALTH ENHANCEMENT ADVISORY SERVICES, LLCADD81,556102,759+26.0%$191.1K2026-Q1
Mariner, LLCADD54,52672,541+33.0%$132.0K2026-Q1
MetLife Investment Management, LLCTRIM91,61863,517-30.7%$115.6K2026-Q1
SEI INVESTMENTS COADD22,14034,676+56.6%$63.1K2026-Q1
PRUDENTIAL FINANCIAL INCDOUBLED10,81828,538+163.8%$51.9K2026-Q1
GROUP ONE TRADING LLCTRIM21,64412,128-44.0%$22.1K2026-Q1
Allworth Financial LPADD2,6463,391+28.2%$6.2K2026-Q1
LOS ANGELES CAPITAL MANAGEMENT LLCNEAR_EXIT365,987140-100.0%$255.002026-Q1
TWO SIGMA INVESTMENTS, LPADD1,144,4321,857,110+62.3%$3.8M2025-Q4
Connor, Clark & Lunn Investment Management Ltd.DOUBLED274,739653,190+137.7%$1.3M2025-Q4
RENAISSANCE TECHNOLOGIES LLCTRIM839,500498,000-40.7%$1.0M2025-Q4
Invesco Ltd.ADD240,081309,168+28.8%$636.9K2025-Q4
LAZARD ASSET MANAGEMENT LLCTRIM477,791273,551-42.7%$563.5K2025-Q4
WELLS FARGO & COMPANY/MNADD141,392228,463+61.6%$470.6K2025-Q4
HSBC HOLDINGS PLCDOUBLED101,808203,922+100.3%$421.1K2025-Q4
FRANKLIN RESOURCES INCDOUBLED31,559149,427+373.5%$307.8K2025-Q4
Mariner, LLCADD40,54254,526+34.5%$112.5K2025-Q4
PRUDENTIAL FINANCIAL INCTRIM22,66510,818-52.3%$22.3K2025-Q4
11 unique insiders with 38 transactions. Net insider value: -$2.7M ($0.00 bought, $2.7M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 9, 2026BJERKHOLT ERICDirectorSELL20,454$2.60$53.2K
Jun 2, 2026Lucena AnnDirectorAWARD60,000——
Jun 2, 2026BJERKHOLT ERICDirectorAWARD60,000——
Jun 2, 2026NACHTSHEIM JAMI KDirectorAWARD60,000——
Jun 2, 2026Witney FrankDirectorAWARD60,000——
Jun 2, 2026Gregory Dean A.DirectorAWARD60,000——
Jun 2, 2026Shan HuaDirectorAWARD60,000——
May 29, 2026Jayaraman Vivek KChief Operating OfficerSELL16,667$3.00$50.0K
May 1, 2026Jayaraman Vivek KChief Operating OfficerSELL16,667$3.00$50.0K
Apr 1, 2026Green Kevin DennisChief Financial OfficerAWARD200,000——
Apr 1, 2026Jensen ChrystalChief Legal OfficerAWARD200,000——
Mar 12, 2026Greenman William MarinerPresident and CEOSELL447,757$1.66$742.0K
Mar 12, 2026Jayaraman Vivek KChief Operating OfficerSELL165,200$1.66$273.8K
Mar 12, 2026Green Kevin DennisChief Financial OfficerSELL127,544$1.66$211.4K
Mar 12, 2026Benjamin Richard JChief Medical OfficerSELL101,740$1.66$168.6K
Mar 9, 2026Benjamin Richard JChief Medical OfficerSELL40,426$1.88$76.0K
Mar 9, 2026Benjamin Richard JChief Medical OfficerSELL40,426$1.88$76.0K
Mar 6, 2026Jensen ChrystalChief Legal OfficerSELL30,845$2.01$61.9K
Mar 6, 2026Green Kevin DennisChief Financial OfficerSELL27,796$2.01$55.7K
Mar 6, 2026Greenman William MarinerPresident and CEOSELL78,187$2.01$156.8K
Mar 6, 2026Jayaraman Vivek KChief Operating OfficerSELL34,094$2.01$68.4K
Mar 6, 2026Benjamin Richard JChief Medical OfficerSELL24,235$2.01$48.6K
Mar 6, 2026Benjamin Richard JChief Medical OfficerSELL24,235$2.01$48.6K
Mar 5, 2026Jensen ChrystalChief Legal OfficerAWARD55,220——
Mar 5, 2026Green Kevin DennisChief Financial OfficerAWARD63,854——
Mar 5, 2026Green Kevin DennisChief Financial OfficerSELL55,225$2.06$113.9K
Mar 5, 2026Greenman William MarinerPresident and CEOAWARD193,270——
Mar 5, 2026Jayaraman Vivek KChief Operating OfficerAWARD80,320——
Mar 5, 2026Benjamin Richard JChief Medical OfficerSELL61,233$2.06$126.3K
Mar 5, 2026Benjamin Richard JChief Medical OfficerAWARD55,220——
Mar 5, 2026Benjamin Richard JChief Medical OfficerSELL61,233$2.06$126.3K
Mar 5, 2026Benjamin Richard JChief Medical OfficerAWARD55,220——
Mar 2, 2026Jayaraman Vivek KChief Operating OfficerAWARD420,000——
Mar 2, 2026Greenman William MarinerPresident and CEOAWARD1,200,000——
Mar 2, 2026Benjamin Richard JChief Medical OfficerAWARD264,000——
Mar 2, 2026Jensen ChrystalChief Legal OfficerAWARD300,000——
Mar 2, 2026Green Kevin DennisChief Financial OfficerAWARD300,000——
Mar 12, 2025Jensen ChrystalChief Legal OfficerSELL113,008$1.66$187.3K
6 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 4 neutral. Avg impact: 4.3/10.
BULLISH 8-K 7/10
Cerus Corp reported Q1 2026 product revenue of $53.7M (+24% YoY), beating consensus estimates, and n
Apr 30, 2026
NEUTRAL DEFA14A 3/10
Cerus Corporation filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, proposin
Apr 22, 2026
NEUTRAL 8-K 3/10
Cerus Corporation adopted a new severance plan on April 17, 2026, establishing enhanced severance be
Apr 21, 2026
BEARISH CLUSTER 6/10
Multiple C-suite executives at Cerus Corp, including the CEO, CFO, CMO, and other senior officers, c
Mar 10, 2026
NEUTRAL CLUSTER 4/10
Seven C-suite executives at Cerus Corp sold shares in a concentrated 7-day window, generating $708K
Mar 10, 2026
NEUTRAL CLUSTER 3/10
Cerus Corp executives, including the CEO, COO, and Chief Legal Officer, sold shares worth $287K in o
Mar 10, 2026
∅

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Strong Buy (89% buy). Based on 9 analysts: 3 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$4.67 mean target +82.3% upside Strong Buy (1.00)
$4.00 Low $5.00 High
MetricValue
Current Price$2.56
Target Low$4.00
Target Mean$4.67
Target Median$5.00
Target High$5.00
# Analysts3
RecommendationStrong Buy (1.00)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
 $-0.01 $-0.01 $-0.01 66.7% +60.0% 0↑ 1↓ $0.1B 12.3% 2
Next Q
2026-09-30
 $-0.01 $-0.01 $-0.01 0.0% -100.0% 0↑ 1↓ $0.1B 13.7% 2
Current FY
2026-12-31
 $-0.03 $-0.04 $-0.02 62.5% +50.0% 0↑ 2↓ $0.2B 15.5% 2
Next FY
2027-12-31
 $0.00 $-0.03 $0.03 100.0% +100.0% 0↑ 1↓ $0.3B 9.1% 2

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.010
7d ago$-0.025+0.015
30d ago$-0.025+0.015
60d ago$0.000-0.010
90d ago$0.000-0.010
1 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 1, 2026 BTIG UPGRADE Neutral Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20263510089%
May 1, 20262520078%
Apr 1, 20262520078%
Mar 1, 20262620080%
Feb 1, 20262620080%
Jan 1, 20262620080%
Strong BuyBuyHoldSellStrong Sell
∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

∅

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 15, 2026
short_volume
Short Volume: CERS — 55.5% short (0.6M / 1.1M)
Short: 612,926 | Exempt: 25 | TRF Vol: 1,104,545 | Short Ratio: 55.5% | Off-exchange volume (dark pool + OTC)
May 4, 2026
Clinical Trial
INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections
Phase Phase 3 — ACTIVE_NOT_RECRUITING
May 4, 2026
clinical_trial_readout
T-90d Trial Readout: INTERCEPT Blood System for RBCs Study in Regions a (Phase 3)
Trial: INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections Sponsor: Cerus Corporation
May 2, 2026
clinical_trial_readout
T-90d Trial Readout: INTERCEPT Blood System for RBCs Study in Regions a (Phase 3)
Trial: INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections Sponsor: Cerus Corporation
Apr 30, 2026
earnings_calendar
CERS Q1 2026 Earnings Scheduled — 2026-04-30
Mar 31, 2026
short_volume
Short Volume: CERS — 65.6% short (0.4M / 0.6M)
Short: 402,404 | Exempt: 9 | TRF Vol: 613,771 | Short Ratio: 65.6% | Off-exchange volume (dark pool + OTC)
Mar 27, 2026
short_volume
Short Volume: CERS — 68.5% short (0.4M / 0.5M)
Short: 368,870 | Exempt: 5,000 | TRF Vol: 538,431 | Short Ratio: 68.5% | Off-exchange volume (dark pool + OTC)
Mar 25, 2026
short_volume
Short Volume: CERS — 62.3% short (0.7M / 1.1M)
Short: 666,287 | Exempt: 28 | TRF Vol: 1,069,949 | Short Ratio: 62.3% | Off-exchange volume (dark pool + OTC)
Mar 23, 2026
short_volume
Short Volume: CERS — 65.5% short (0.5M / 0.7M)
Short: 465,532 | Exempt: 0 | TRF Vol: 711,191 | Short Ratio: 65.5% | Off-exchange volume (dark pool + OTC)
Mar 2, 2026
earnings_calendar
CERS Q4 2025 Earnings After Market Close — 2026-03-02